Website Search
ID 15046

Better cancer therapies by identifying oncogenes, David Botstein

Interviewee: David Botstein. David Botstein discusses how identifying the molecular mechanisms of cancer will lead to the development of improved therapies. (DNAi Location: Applications > Genes and medicine > Genetic profiling > David Botstein Better therapies)
There are also gene expression patterns that are characteristic of particular kinds of oncogene activities and then if you can identify the oncogene that is characteristically over expressed or poorly expressed in a particular tumor, you can then make drugs against it and Gleevec™ and Iressa™ are drugs of that kind.
gene expression patterns,david botstein,cancer diagnosis,cancer therapies,genetic profiling,molecular mechanisms,location applications,dnai,oncogenes,iressa,oncogene,interviewee,mechanisms of cancer,genes,tumor,dna,drugs,medicine
Creative Commons License This work by Cold Spring Harbor Laboratory is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License.

Related content:

15048. Better diagnosis, David Botstein
David Botstein talks about the goal of using microarray analysis to improve cancer diagnosis.
15121. Little known in the 1970s about the causes of cancer, Mary-Claire King
Mary-Claire King speaks about how much was yet to be understood about the genetic mechanisms of cancer when she began her hunt for genes associated with breast cancer.
15047. Promises of genomics, David Botstein
David Botstein (sitting with Pat Brown) talks about how innovations in genomics might lead to personalized medicine.
15045. Why tumor typing is important, David Botstein
David Botstein talks about how tumor typing using genome-wide analysis will help doctors determine the most appropriate treatments for their patients.
15053. Gene profile and response to treatment, Stephen Fodor
Stephen Fodor talks about how an individual's gene expression profile can help determine what therapies might work best.
15040. Using DNA microarrays to study cancer, Patrick Brown
Pat Brown talks about using microarrays to discover the differences between cancer cells and healthy cells.
1009. Diagnosis, Pharmacogenetics
In this section pharmacogenetics is discussed and how people can have very different responses to the same drug and treatment.
970. Causes, Inheritance: Cancer gene types
This section identifies that a cancer gene alters the normal functioning of a protein, and there are three major categories of cancer genes.
969. Causes, Inheritance
All cancers are genetic, in that cancers are caused by genetic mutations in genes that lead to malignancy.
971. Causes, Inheritance: Cancer gene types, Vogelstein clip 1
Professor Bert Vogelstein, explains that cancer is in essence a genetic disease. It is caused by mutations of genes and there are three types of genes, that contribute to cancer.
Cold Spring Harbor Laboratory
CSHL HomeAbout CSHLResearchEducationNews & FeaturesCampus & Public EventsCareersGiving